Oceanpine Capital

Xingchen New Energy develops new generation of ultra-high-performance all-vanadium flow energy storage system, fully covering electrolyte, stack and core R&D, manufacturing and production of components, energy storage systems and other products, and provide safer comprehensive energy storage solutions.

Blue Wave is a producer of Industrial IoT and Internet of Vehicles chips.

Renxin Technology is an automotive chip design company. It provides competitive chip and system solutions for the industry and follows the evolution and development of automotive EE architecture.

Kuixin Technology specializes in the development of integrated circuits designed to address the challenges of computing power scaling and high-speed interconnection. The company offers a diverse range of products, including USB, PCIe, SATA, SerDes, MIPI, DDR, HDMI, DP, and HBM chipsets. These solutions cater to various applications, including data centers, artificial intelligence, consumer electronics, automotive technology, and the Internet of Things (IoT). By focusing on innovative circuitry, Kuixin aims to enhance performance and connectivity across multiple sectors.

SIRUI is an intelligent technology company that concentrates on the growth of strategic emerging industries and key core technologies such as semiconductor equipment and new display. Their products include atomic layer deposition coating equipment and thin-film electroluminescence displays. Its overseas technology research and development center will gradually conduct research, development, and industrialization of ALD and EL technology. It provides mature and leading ALD coating solutions for global customers in industrial coating applications such as semiconductors and optoelectronics, and it aids in the development of related industries such as semiconductors.

Qinghai Lihao specializes in the research, development, production, and sales of crystalline silicon, particularly for use in semiconductor materials. The company is dedicated to mass production of high-purity crystalline silicon, which supports the renewable energy sector and meets the demands of clients in the semiconductor industry. By focusing on process technology, Qinghai Lihao aims to advance its capabilities in the new energy business while ensuring the availability of essential materials for various applications.

Enflame Technology specializes in developing neural network solutions tailored for artificial intelligence applications. The company's primary offerings include high-end deep learning chips designed specifically for cloud data centers and AI training platforms. These chips feature a proprietary architecture that emphasizes high computational power and energy efficiency, while also being programmable and cost-effective. Enflame Technology's products are optimized for mainstream machine learning frameworks, making them suitable for a wide range of AI training and optimization tasks.

Huachen Core Light is a semiconductor technology company that produces and manufactures optical communications and laser chips.

Aqronos is a technology company that specializes in the development of advanced LiDAR sensors aimed at enhancing autonomous driving and driver assistance systems. Their innovative solutions provide vehicles with exceptional vision capabilities, effectively transforming them into guardians on the road. By utilizing cutting-edge LiDAR technology, Aqronos aims to improve safety for drivers and passengers alike, ensuring a more secure driving experience.

Shenzhen Shifeng offers industrial software, digital twin systems, and a simulation cloud service platform. The company serves marine engineering, aerospace, energy, electronic appliances, car traffic, and engineering manufacturing.

Clounix is a software startup specializing in high-performance network chips and solutions. The company focuses on developing application-specific integrated circuits (ASICs) designed for cloud networking, which enhance high-speed packet switching capabilities. By emphasizing low latency and ultra-high-speed principles, Clounix supports super-internet companies, medium and large enterprises, and network operators in building next-generation networks and data centers. Their efforts include creating both the underlying hardware and customized software that align with cloud-native environments, thereby facilitating the advancement of cutting-edge networking technology.

Liansu Technology is a software company specializing in the development of high-performance graphics rendering GPUs. The company focuses on creating domestically-made GPU chips using self-developed architecture and proprietary intellectual property. Liansu aims to serve the expansive domestic market for rendering GPUs, which is valued at 200 billion, by delivering high-performance graphics rendering solutions across various platforms, including devices, cloud computing, and automotive applications. Its products cater to diverse industries such as gaming, digital twins, the metaverse, virtual and augmented reality, ultra-high-definition video, and professional design. By leveraging its advanced technology, Liansu Technology provides partners with comprehensive software and hardware solutions tailored to meet the evolving needs of the digital economy.

OrthoGuard Physicians is a comprehensive orthopedic medical service organization based in China, focusing on the treatment and diagnosis of various musculoskeletal conditions, including joint, spine, ankle, and trauma injuries. The company emphasizes efficient management and innovative operational models to enhance patient care, facilitating quicker healing and improved recovery experiences. In addition to direct medical services, OrthoGuard is involved in hospital management, rehabilitation services, and education and training initiatives. The organization also engages in supply chain management and the establishment of demonstration diagnosis and treatment centers, aiming to create a reputable and innovative medical group in the orthopedic field. Through these efforts, OrthoGuard seeks to leverage its extensive resources and expertise to advance orthopedic healthcare in China.

Erised Semiconductor is a circuit designer and manufacturer that provides users with display driver and power management chips. The applications can be found in radiofrequency applications, discrete devices, and other products.

Chipone Technology is a prominent chip design company that specializes in display solutions, positioning itself as a competitive player in the global market. The company's product portfolio includes a comprehensive range of display chips, such as TDDI (display driver and touch integrated chip), medium and large size display driver chips, OLED display chips, power management chips, LED display driver chips, timing control chips, fingerprint recognition chips, and touch control chips, including silicon-based OLED chips. Chipone's innovative technologies are utilized across various applications, including televisions, monitors, notebooks, tablets, smartphones, and wearable devices. The company serves a diverse clientele, comprising leading global panel manufacturers, top-tier domestic mobile device brands, and renowned LED display manufacturers.

MingMed is a Chinese pharmaceutical company focused on independent drug research and development, demonstrating strong global competitiveness. The company specializes in a diverse product pipeline that includes ophthalmic drugs, recombinant protein botulinum toxin, tumor immune drugs, and immune therapies for pets. MingMed also emphasizes innovation, with several potential First-in-Class drugs currently in the clinical stage. Its research spans various therapeutic areas, delivering cutting-edge solutions in ophthalmology, medical aesthetics, and veterinary medicine, particularly through small molecule immune drugs and gene editing-based cell therapies.

SVOLT manufacturer of electric batteries. They specialize in the manufacturing of automotive power batteries and energy storage systems. Their market applications include passenger cars, commercial vehicles, energy storage, and light power solutions. Their products include batteries and energy storage batterie. They provide users with energy vehicle charging piles, batteries recycling, and solutions.

Tongshu Gene is a high-tech enterprise specializing in tumor precision medicine. The company offers gene testing services and develops advanced diagnostic molecular pathology projects, as well as ctDNA precision detection systems. Utilizing high-throughput gene sequencing technology and biological information analysis, Tongshu Gene aims to enhance clinical decision-making by providing consulting services that include precision medication, efficacy monitoring, postoperative recurrence monitoring, risk prediction, and early detection of tumors. Through its innovative approach, the company supports clinicians in improving patient outcomes in cancer treatment and management.

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.

Weilong Foods is a prominent snack food brand based in Luohe, Henan Province, China, specializing in the production and sale of spicy snack foods. Founded in 1999 by Liu Weiping and Liu Fuping, the company operates through various business units categorized into three main segments: seasoned flour products, vegetable products, and bean-based and other products. The seasoned flour products, which include items like Big Latiao and Spicy Hot Stick, generate the majority of the company's revenue. In addition to these, Weilong Foods also offers products such as Konjac Shuang and Soft Tofu Skin, catering to a diverse consumer base within the Chinese market.

Hepagene Therapeutics is a biopharmaceutical company focused on developing innovative treatments for liver diseases. The company is dedicated to researching and creating therapies for conditions such as non-alcoholic steatohepatitis (NASH), chronic Hepatitis B infection, and liver cancer. Hepagene Therapeutics aims to address the significant unmet medical needs in the field of hepatology, striving to improve patient outcomes through its targeted drug development efforts.

TechnoDerma Medicines is a private clinical-stage biopharmaceutical company dedicated to the development of innovative therapies for various skin diseases. The company focuses on creating small molecular drugs aimed at treating conditions such as androgenetic alopecia, atopic dermatitis, psoriasis, lupus erythematosus, and scars. By prioritizing research and development, TechnoDerma Medicines seeks to provide patients with safe and effective treatment options to improve their quality of life and address unmet medical needs in dermatological care.

Immune-Onc Therapeutics, Inc. is a biopharmaceutical company based in Palo Alto, California, founded in 2016. The company specializes in the discovery and development of innovative biologic treatments, particularly aiming to create therapeutic antibodies for cancer. Immune-Onc Therapeutics leverages scientific insights related to the tumor microenvironment and immune suppressive pathways to develop first-in-class biotherapeutics. By targeting myeloid cells, it aims to disarm immune suppression within tumors, facilitating new immunomodulatory approaches for cancer treatment. The company's focus on advancing novel immuno-oncology products positions it to provide effective new treatment options for cancer patients.

Julive is a new house transaction service platform.

Yisheng Biopharma Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and marketing of immuno-oncology products and vaccines. Founded in 2002 and headquartered in Beijing, the company operates in China, the United States, Cambodia, and Singapore. Yisheng Biopharma utilizes its novel PIKA immunomodulating technology to enhance immune responses against cancers and infectious diseases. Key products under development include YS-ON-001, an investigational therapy aimed at treating advanced solid tumors, as well as YS-HBV-001, a vaccine for hepatitis B, and a PIKA-based rabies vaccine designed for rapid protection against rabies infection. The company's innovative approach targets multiple immune pathways to improve treatment outcomes.

Teon Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Redwood, California, focused on advancing cancer immunotherapy. Founded in 2018, the company specializes in the discovery and development of small molecule drugs aimed at inhibiting immunosuppressive and cancer-promoting signaling pathways within the tumor microenvironment. Teon Therapeutics is dedicated to improving the lives of cancer patients by developing a targeted portfolio of molecules that not only restore antitumor immunity but also suppress cancer cell proliferation. Their lead program involves an A2BR-specific antagonist that is set to enter Phase 1b clinical trials. By integrating metabolic checkpoint inhibitors and GPCR immune checkpoint inhibitors, Teon aims to enhance the efficacy of existing immunotherapies and improve long-term outcomes for cancer patients.

Clover Biopharmaceuticals, established in 2016, is a global, clinical-stage biotech company dedicated to discovering, developing, and commercializing innovative biologics targeting trimerization-dependent pathways in oncology and autoimmune diseases. The company's proprietary Trimer-Tag© technology platform enables the creation of novel biologics. Additionally, Clover employs its in-house cGMP biomanufacturing capabilities for select biosimilars development.

Sinovent, established in 2016, is a global biopharmaceutical company with headquarters in Suzhou, China, and offices in Beijing, China, and Boston, U.S.A. It specializes in developing advanced treatments for global healthcare challenges, with a focus on oncology, autoimmune diseases, and infectious diseases. Sinovent's portfolio comprises 12 products in various stages of development, leveraging its expertise in science, management, and finance to deliver innovative solutions to patients worldwide.

XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

Guangzhou Creative Biosciences, established in Guangzhou, China, specializes in the research, development, production, and sales of diagnostic kits for colorectal cancer screening. Their primary product is a non-invasive fecal DNA screening kit, which enables early detection of colorectal cancer by interpreting genetic abnormalities in feces. Additionally, the company offers diagnostic kits and equipment for lung cancer.

Triumvira Immunologics USA, Inc. is an immunotherapy company founded in 2015 and headquartered in Austin, Texas, with research facilities in Hamilton, Canada. The company focuses on developing innovative T cell therapies aimed at improving cancer treatment outcomes. Its primary offerings include chimeric antigen receptor (CAR) therapies and engineered T cell receptor (TCR) therapies. A key aspect of Triumvira's approach is its proprietary T cell Antigen Coupler (TAC) technology, which recruits the entire natural T cell receptor and operates independently of the major histocompatibility complex (MHC). This technology enables the development of more effective therapies for a wider array of patients suffering from both solid and liquid malignancies, as well as other diseases beyond cancer.

Sinovent, established in 2016, is a global biopharmaceutical company with headquarters in Suzhou, China, and offices in Beijing, China, and Boston, U.S.A. It specializes in developing advanced treatments for global healthcare challenges, with a focus on oncology, autoimmune diseases, and infectious diseases. Sinovent's portfolio comprises 12 products in various stages of development, leveraging its expertise in science, management, and finance to deliver innovative solutions to patients worldwide.

hireEZ is an AI-powered outbound recruitment platform designed to simplify the recruiting process for organizations. By enabling recruiters to proactively connect jobs with potential candidates, hireEZ aims to transform the traditional hiring approach from inbound to outbound strategies. The platform provides valuable market insights, allowing businesses to identify and engage the right talent effectively. Through its innovative solutions, hireEZ addresses the challenges of the competitive talent acquisition landscape, helping organizations build more inclusive workplaces and achieve their hiring goals.

Enflame Technology specializes in developing neural network solutions tailored for artificial intelligence applications. The company's primary offerings include high-end deep learning chips designed specifically for cloud data centers and AI training platforms. These chips feature a proprietary architecture that emphasizes high computational power and energy efficiency, while also being programmable and cost-effective. Enflame Technology's products are optimized for mainstream machine learning frameworks, making them suitable for a wide range of AI training and optimization tasks.

Apexigen Inc. is a clinical-stage biopharmaceutical company based in San Carlos, California, focused on developing antibody therapeutics for cancer treatment. Established in 2010, Apexigen specializes in immuno-oncology, creating therapies that aim to leverage the patient's immune system to effectively combat and eradicate cancer. The company's pipeline includes several promising candidates, such as APX005M and APX201 for immuno-oncology, along with additional programs targeting various oncology and inflammation conditions. Notably, its lead candidate, sotigalimab, is currently in clinical development, complemented by a range of preclinical immuno-oncology programs. Apexigen also utilizes its proprietary APXiMAB platform to discover novel antibodies targeting immune system pathways, underscoring its commitment to advancing innovative treatments in cancer care.

Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.

Ansun Biopharma, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing innovative therapies to prevent and treat severe human diseases. The company specializes in host-directed anti-viral therapies aimed at addressing respiratory viral infections, such as influenza and parainfluenza viruses, by targeting the host rather than the virus itself. Its product pipeline includes Fludase, which is designed for the prophylaxis and treatment of influenza-related respiratory infections, and Viradin, an intravenous therapeutic for sepsis and viral hemorrhagic fever caused by pathogens like Ebola and Marburg viruses. Additionally, Ansun Biopharma has developed TOSAP, a technology for creating microspheres and nanospheres for drug delivery. Founded in 2003 and originally named NexBio, Inc., the company rebranded to Ansun Biopharma in 2011, reflecting its commitment to addressing critical health challenges through advanced biopharmaceutical solutions.

Enflame Technology specializes in developing neural network solutions tailored for artificial intelligence applications. The company's primary offerings include high-end deep learning chips designed specifically for cloud data centers and AI training platforms. These chips feature a proprietary architecture that emphasizes high computational power and energy efficiency, while also being programmable and cost-effective. Enflame Technology's products are optimized for mainstream machine learning frameworks, making them suitable for a wide range of AI training and optimization tasks.

Horizon Robotics is a prominent provider of advanced driver assistance systems (ADAS) and autonomous driving solutions specifically designed for passenger vehicles. The company develops proprietary software and hardware that integrate advanced algorithms and specialized processing capabilities. These technologies form the foundation for enhanced driving automation, aiming to improve both safety and the overall experience for drivers and passengers. By focusing on innovative solutions, Horizon Robotics plays a key role in the evolution of assisted and autonomous driving.

Inspirna is a clinical-stage biopharmaceutical company focused on developing innovative drug candidates that target essential drivers of cancer. Utilizing a discovery platform centered on RNA biology, Inspirna identifies novel cancer targets that contribute to tumor growth and disease progression. The company is advancing several first-in-class oral small molecules, including RGX-202, aimed at treating patients with RAS mutant colorectal cancer, and RGX-104, which is in development for small cell lung cancer and non-small cell lung cancer. Through its microRNA-based target discovery approach, Inspirna seeks to provide effective treatment options for cancer patients by employing targeted therapies that leverage small molecules and biologics.

51Zhaoyou.com operates as a B2B ecommerce platform dedicated to the petroleum industry in China. It facilitates transactions through an online marketplace, offering comprehensive services including fuel trading, logistics management, and financial solutions tailored for its client base comprising leading logistics companies.

Tiger Brokers, established in 2014, is a leading online brokerage firm specializing in facilitating global investments for Chinese investors. The company's platform enables users to trade equities and other financial instruments across multiple exchanges worldwide. Tiger Brokers offers comprehensive services including order placement and execution, margin financing, account management, investor education, community discussion forums, and customer support.

Ansun Biopharma, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing innovative therapies to prevent and treat severe human diseases. The company specializes in host-directed anti-viral therapies aimed at addressing respiratory viral infections, such as influenza and parainfluenza viruses, by targeting the host rather than the virus itself. Its product pipeline includes Fludase, which is designed for the prophylaxis and treatment of influenza-related respiratory infections, and Viradin, an intravenous therapeutic for sepsis and viral hemorrhagic fever caused by pathogens like Ebola and Marburg viruses. Additionally, Ansun Biopharma has developed TOSAP, a technology for creating microspheres and nanospheres for drug delivery. Founded in 2003 and originally named NexBio, Inc., the company rebranded to Ansun Biopharma in 2011, reflecting its commitment to addressing critical health challenges through advanced biopharmaceutical solutions.